Company intelligence
Ora
The Ophthalmology Research Company
About Ora
Ora is the world's leading full-service ophthalmic drug and device development firm with offices in the United States, United Kingdom, Australia, and Asia. For over 50 years, we have proudly helped our clients earn more than 90 product approvals. We support a wide array of organizations, from start-ups to global pharmaceutical and device companies, to efficiently bring their new products from concept to market. Ora's pre-clinical and clinical models, unique methodologies, integrated clinical data solutions, and global regulatory strategies have been refined and proven across thousands of global projects. We bring together the world's most extensive and experienced team of ophthalmic experts, R&D professionals, and management executives to maximize the value of new product initiatives.
Verified activity
Signals from Ora
3 published signals
Partnerships
Ora announced a collaboration between the World Council of Optometry, Alcon, and International Association of Contact Lens Educators to bring practical educational tools directly to educators and students globally.
Reported by Ora
Presence & Recognition
Ora is attending the ESCRS 2026 Glaucoma Day with the European Society of Cataract and Refractive Surgeons and European Glaucoma Society.
Reported by Ora
Presence & Recognition
Ora's Chief Medical Officer Gustavo De Moraes, MD, PhD, MPH, is speaking at the Brazilian Academy of Ophthalmology Meeting from September 9 to 12.
Reported by Ora